0001209191-19-031833.txt : 20190521
0001209191-19-031833.hdr.sgml : 20190521
20190521182722
ACCESSION NUMBER: 0001209191-19-031833
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190517
FILED AS OF DATE: 20190521
DATE AS OF CHANGE: 20190521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mow Jonathan P
CENTRAL INDEX KEY: 0001313942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 19843600
MAIL ADDRESS:
STREET 1: 2025 1ST AVENUE
STREET 2: SUITE 800
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-17
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001313942
Mow Jonathan P
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
1
1
0
0
Chief Executive Officer
Common Stock
2019-05-17
4
M
0
19913
2.27
A
71112
D
Common Stock
2019-05-20
4
M
0
19131
1.24
A
90243
D
Employee stock option (right to buy)
2.27
2019-05-17
4
M
0
19913
0.00
D
2016-12-03
2022-12-21
Common Stock
19913
0
D
Employee stock option (right to buy)
1.24
2019-05-20
4
M
0
19131
0.00
D
2018-03-14
2024-03-31
Common Stock
19131
0
D
/s/ John Sharp, Attorney-in-fact
2019-05-21